Status:
COMPLETED
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
University of Minnesota
Conditions:
Cocaine-Related Disorders
Eligibility:
FEMALE
18-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the effects of nefazedone on cocaine self-administration in depressed and non-depressed female cocaine users.
Detailed Description
This study evaluated the effect of nefazodone on reducing cocaine use and craving in both depressed and nondepressed women and if there was a greater effect in depressed women.
Eligibility Criteria
Inclusion Criteria:
Females, ages 18-55, minimum use of 8 days of the last 30, minimum of 8th grade education, current diagnosis of cocaine abuse/dependence
Exclusion Criteria:
Unstable medical illness, dx of MR, OBS, bipolar
Key Trial Info
Start Date :
December 1 1996
Trial Type :
INTERVENTIONAL
End Date :
December 1 2001
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000286
Start Date
December 1 1996
End Date
December 1 2001
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455